Keyphrases
T Cells
100%
Leishmania
100%
Cutaneous Leishmaniasis
100%
Epitope
100%
Peripheral Blood Mononuclear Cells
100%
Amastigote Antigens
100%
Leishmania Braziliensis
40%
Cytokine Production
40%
Amastigote
40%
Immune Response
20%
Leishmania Vaccine
20%
Interleukin-4 (IL-4)
20%
Vaccine Development
20%
Brazil
20%
Human Patients
20%
Proliferative Response
20%
Murine Cutaneous Leishmaniasis
20%
Interferon-α (IFN-α)
20%
Nineteen
20%
Interferon-γ
20%
Interferon Production
20%
Interferon Response
20%
T Cell Proliferation
20%
Significant Level
20%
Human Response
20%
Multiple Epitopes
20%
Stimulation Index
20%
Whole Parasite
20%
Immunology and Microbiology
T Cell
100%
Leishmania
100%
Cutaneous Leishmaniasis
100%
Epitope
100%
Amastigote
100%
Peripheral Blood Mononuclear Cell
100%
interferon
40%
Cytokine Production
40%
Immune Response
20%
Leishmania Vaccine
20%
Interleukin 4
20%
Homogenate
20%
Interferon Production
20%
T Cell Proliferation
20%
Interferon Gamma
20%
Leishmania braziliensis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Skin Leishmaniasis
100%
Leishmania
100%
Epitope
100%
Amastigote
100%
Cytokine
66%
Interferon
66%
Disease
33%
Infection
33%
Leishmania Vaccine
33%
Vaccine Development
33%
Gamma Interferon
33%
Interleukin 4
33%
Leishmania braziliensis
33%
Glycine Dehydrogenase (Decarboxylating)
33%